Kuros Biosciences AG (KURN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.029x

Based on the latest financial reports, Kuros Biosciences AG (KURN) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF1.94 Million ≈ $2.46 Million USD) by net assets (CHF66.93 Million ≈ $84.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KURN days of operational coverage to measure how many days the company can operate on defensive assets alone.

Kuros Biosciences AG - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Kuros Biosciences AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kuros Biosciences AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kuros Biosciences AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ridley Corporation Ltd
AU:RIC
0.154x
Changhong Meiling Co Ltd
SHE:000521
-0.004x
Sgis Songshan Co Ltd
SHE:000717
0.093x
Quanex Building Products
NYSE:NX
0.026x
Fox Factory Holding Corp
NASDAQ:FOXF
0.005x
Swissquote Group Holding SA
SW:SQN
0.300x
Shaanxi Construction Machinery Co Ltd
SHG:600984
0.029x
China Fortune Land Development Co Ltd
SHG:600340
0.076x

Annual Cash Flow Conversion Efficiency for Kuros Biosciences AG (2004–2025)

The table below shows the annual cash flow conversion efficiency of Kuros Biosciences AG from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see KURN market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF66.93 Million
≈ $84.62 Million
CHF-377.87K
≈ $-477.73K
-0.006x -110.56%
2024-12-31 CHF58.75 Million
≈ $74.27 Million
CHF3.14 Million
≈ $3.97 Million
0.053x +134.27%
2023-12-31 CHF56.71 Million
≈ $71.70 Million
CHF-8.84 Million
≈ $-11.18 Million
-0.156x -46.14%
2022-12-31 CHF68.86 Million
≈ $87.06 Million
CHF-7.35 Million
≈ $-9.29 Million
-0.107x -50.63%
2021-12-31 CHF76.98 Million
≈ $97.32 Million
CHF-5.45 Million
≈ $-6.89 Million
-0.071x +35.13%
2020-12-31 CHF84.60 Million
≈ $106.96 Million
CHF-9.24 Million
≈ $-11.68 Million
-0.109x +21.63%
2019-12-31 CHF77.86 Million
≈ $98.43 Million
CHF-10.85 Million
≈ $-13.72 Million
-0.139x +16.98%
2018-12-31 CHF76.48 Million
≈ $96.70 Million
CHF-12.84 Million
≈ $-16.23 Million
-0.168x -14.97%
2017-12-31 CHF73.14 Million
≈ $92.47 Million
CHF-10.68 Million
≈ $-13.50 Million
-0.146x +37.09%
2016-12-31 CHF38.32 Million
≈ $48.45 Million
CHF-8.89 Million
≈ $-11.24 Million
-0.232x +93.82%
2015-12-31 CHF669.00K
≈ $845.80K
CHF-2.51 Million
≈ $-3.18 Million
-3.758x -514.73%
2014-12-31 CHF-26.22 Million
≈ $-33.15 Million
CHF-23.76 Million
≈ $-30.04 Million
0.906x +119.99%
2013-12-31 CHF4.23 Million
≈ $5.35 Million
CHF-19.17 Million
≈ $-24.24 Million
-4.532x -293.95%
2012-12-31 CHF10.03 Million
≈ $12.68 Million
CHF-11.54 Million
≈ $-14.59 Million
-1.150x -252.56%
2011-12-31 CHF-11.68 Million
≈ $-14.77 Million
CHF-8.81 Million
≈ $-11.13 Million
0.754x +206.14%
2010-12-31 CHF6.59 Million
≈ $8.34 Million
CHF-4.68 Million
≈ $-5.92 Million
-0.710x +61.61%
2009-12-31 CHF8.24 Million
≈ $10.42 Million
CHF-15.25 Million
≈ $-19.28 Million
-1.850x -111.33%
2008-12-31 CHF31.86 Million
≈ $40.28 Million
CHF-27.89 Million
≈ $-35.27 Million
-0.876x -983.67%
2007-12-31 CHF54.43 Million
≈ $68.82 Million
CHF-4.40 Million
≈ $-5.56 Million
-0.081x +87.07%
2006-12-31 CHF45.90 Million
≈ $58.03 Million
CHF-28.67 Million
≈ $-36.25 Million
-0.625x -70.75%
2005-12-31 CHF74.01 Million
≈ $93.57 Million
CHF-27.08 Million
≈ $-34.23 Million
-0.366x -29.32%
2004-12-31 CHF80.17 Million
≈ $101.36 Million
CHF-22.68 Million
≈ $-28.68 Million
-0.283x --

About Kuros Biosciences AG

SW:KURN Switzerland Medical Devices
Market Cap
$1.00 Billion
CHF792.91 Million CHF
Market Cap Rank
#10354 Global
#126 in Switzerland
Share Price
CHF20.20
Change (1 day)
-1.94%
52-Week Range
CHF18.82 - CHF33.36
All Time High
CHF36.96
About

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; Ma… Read more